Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE DU CYGNE DE CROIX : revenue, balance sheet and financial ratios

PHARMACIE DU CYGNE DE CROIX is a French company founded 7 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in CAEN (14000), this company of category PME shows in 2022 a revenue of 794 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DU CYGNE DE CROIX (SIREN 840955942)
Indicator 2023 2022 2021 2019
Revenue N/C 794 229 € N/C N/C
Net income -11 589 € 1 628 € 10 874 € -126 430 €
EBITDA N/C 22 038 € N/C N/C
Net margin N/C 0.2% N/C N/C

Revenue and income statement

In 2023, PHARMACIE DU CYGNE DE CROIX records a net loss of 12 k€. This deficit will reduce equity on the balance sheet.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-11 589 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at -207%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -77%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

-206.594%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

-76.605%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

45.8%

Solvency indicators evolution
PHARMACIE DU CYGNE DE CROIX

Sector positioning

Debt ratio
-206.59 2023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Excellent

In 2023, the debt ratio of PHARMACIE DU CYGNE DE CROIX (-206.59) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
-76.61% 2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Watch

In 2023, the financial autonomy of PHARMACIE DU CYGNE DE CROIX (-76.6%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
177.15 years 2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Watch

In 2022, the repayment capacity of PHARMACIE DU CYGNE DE CROIX (177.15) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 173.22. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

173.215

Liquidity indicators evolution
PHARMACIE DU CYGNE DE CROIX

Sector positioning

Liquidity ratio
173.22 2023
2021
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Average -11 pts over 3 years

In 2023, the liquidity ratio of PHARMACIE DU CYGNE DE CROIX (173.22) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
79.89x 2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Excellent

In 2022, the interest coverage of PHARMACIE DU CYGNE DE CROIX (79.9x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE DU CYGNE DE CROIX

Positioning of PHARMACIE DU CYGNE DE CROIX in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DU CYGNE DE CROIX with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DU CYGNE DE CROIX

What is the revenue of PHARMACIE DU CYGNE DE CROIX ?

The revenue of PHARMACIE DU CYGNE DE CROIX in 2022 is 794 k€.

Is PHARMACIE DU CYGNE DE CROIX profitable?

PHARMACIE DU CYGNE DE CROIX recorded a net loss in 2023.

Where is the headquarters of PHARMACIE DU CYGNE DE CROIX ?

The headquarters of PHARMACIE DU CYGNE DE CROIX is located in CAEN (14000), in the department Calvados.

Where to find the tax return of PHARMACIE DU CYGNE DE CROIX ?

The tax return of PHARMACIE DU CYGNE DE CROIX is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DU CYGNE DE CROIX operate?

PHARMACIE DU CYGNE DE CROIX operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.